Michelson Diagnostics Diversifies into Non-Medical Market

Reacting to strong customer demand, Michelson Diagnostics Ltd (MDL) is broadening the commercial application of its unique 'multibeam' Optical Coherence Tomography (OCT) technology into markets outside its core target of cancer diagnosis. These include such diverse areas as industrial metrology, product inspection, tissue engineering and developmental biology.
"We are reacting to customers who have realised that the superior image definition provided by our patented multi-beam OCT technology is very advantageous in their applications", said MDL CEO Jon Holmes. "For a given depth of focus, you get twice the resolution, (or, for a given resolution, four times the focal depth), compared ...
Read Full Article
Login to comment.